NCT04825275 2026-01-23Neuro-pharmacological Properties of Repurposed Posaconazole in Glioblastoma: A Phase 0 Clinical TrialMilton S. Hershey Medical CenterPhase EARLY_PHASE1 Terminated7 enrolled 12 charts
NCT00686543 2017-04-07Oral Posaconazole in High Risk Patients With Gastrointestinal Dysfunction (Study P05115)Merck Sharp & Dohme LLCPhase 4 Completed75 enrolled 14 charts